BioNYRA

BioNYRA Pharma is a clinical-stage biopharmaceuticalcompany developing next-generation mono- and multispecific antibodies forsevere immune-mediated inflammatory diseases, with an initial focus on atopicdermatitis and inflammatory bowel disease. (Bionyra Pharma)

Deal Origin:

External Dealflow / Company Build with SofinnovaPartners — Sofinnova developed the investment thesis, sourced the assets andco-founded the company with Frédéric Marrache. (Sofinnova Partners)

Location:

Paris,France

Build with:

• Frédéric Marrache
• Anta Gkelou / Sofinnova Partners (Sofinnova Partners)

‍

‍